Chiaki Nakaseko
Overview
Explore the profile of Chiaki Nakaseko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
150
Citations
1539
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mishina T, Ohwada C, Suichi T, Matsui S, Ishii A, Takaishi K, et al.
Hematol Oncol
. 2025 Jan;
43(1):e70037.
PMID: 39798588
POEMS syndrome is a multisystemic disease associated with monoclonal plasma cell disorders. Although the presence of bone lesions is included in the diagnostic criteria, their precise manifestations remain unknown. Here,...
2.
Nakao S, Tsukamoto S, Takeda Y, Ohwada C, Ri C, Izumi S, et al.
Int J Hematol
. 2024 Aug;
120(4):501-511.
PMID: 39190255
Criteria for airflow obstruction (AFO) at one year after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in pulmonary function tests (PFTs) are more stringent than the bronchiolitis obliterans syndrome (BOS) criteria...
3.
Ohwada C, Sakaida E, Takeda Y, Doki N, Igarashi A, Onizuka M, et al.
Int J Hematol
. 2024 Jul;
120(3):347-355.
PMID: 39017858
A prospective multicenter observational study of organ response was conducted in patients with chronic GVHD diagnosed by the NIH criteria. When response was assessed at 12 months (12 M) in...
4.
Nakao S, Ngayama D, Nakaseko C, Shimizu N
J Chemother
. 2024 Jul;
:1-7.
PMID: 38989820
Sarcopenia is an independent prognostic factor for several solid cancers, including B-cell non-Hodgkin lymphoma (B-NHL). However, previous reports have measured the parameters of loss of skeletal muscle as sarcopenia only...
5.
Matsumura I, Ohtake S, Atsuta Y, Kurata M, Minami Y, Takahashi N, et al.
Blood Adv
. 2024 Jul;
8(20):5237-5247.
PMID: 38968156
Deep molecular response (DMR) is a prerequite for treatment-free remission (TFR) in chronic myeloid leukemia in chronic phase (CML-CP). The JALSG (Japan Adult Leukemia Study Group) conducted a prospective randomized...
6.
Ishii A, Tsukamoto S, Mimura N, Miyamoto-Nagai Y, Isshiki Y, Matsui S, et al.
Sci Rep
. 2024 May;
14(1):10362.
PMID: 38710832
POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein [M-protein], and skin changes) is a rare systemic disorder characterized by various symptoms caused by underlying plasma cell (PC) dyscrasia. Detection of monoclonal...
7.
Shimizu N, Nakao S, Hasunuma H, Nakaseko C, Shimizu T, Ebinuma H, et al.
Intern Med
. 2024 Mar;
63(20):2767-2771.
PMID: 38432983
Objective We previously reported that patients with acute leukemia and malignant lymphoma (ML) demonstrated significantly increased serum soluble LR11 (sLR11) levels compared to normal controls. Accurately diagnosing ML of the...
8.
Nakao S, Tanaka S, Abe K, Komiyama T, Sugiura Y, Nakaseko C, et al.
Intern Med
. 2023 Nov;
63(13):1923-1927.
PMID: 37981304
In recent years, lesbian, gay, bisexual, and transgender (LGBT) populations have been gaining acceptance in society. However, very few cases of malignancy in the LGBT population have been reported thus...
9.
Kako S, Kimura S, Wada H, Komiya Y, Nakasone H, Sakurai M, et al.
Leuk Res
. 2023 Aug;
133:107371.
PMID: 37595372
The optimal bridge strategy at the decision for allogeneic hematopoietic stem cell transplantation (HSCT) in patients with myelodysplastic syndrome (MDS) is unclear. We performed a prospective observational study in which...
10.
Fuchida S, Ogura M, Ishida T, Hata H, Handa H, Katoh N, et al.
Int J Hematol
. 2023 Jul;
118(4):443-449.
PMID: 37515656
We retrospectively gathered data of 21 patients (13 male and 8 female; median age 65 years) diagnosed with immunoglobulin M (IgM)-related light-chain (AL) amyloidosis in Japan to investigate characteristics of...